# Heartbreakers: Decoding the Molecular Dynamics of Stimulants Abuse on the Cardiovascular System

**Authors:** Cristina Mihaela Stirbu, Anisia-Cristiana Vasiliniuc, Anda Vasiliu, Elisa Anamaria Liehn

PMC · DOI: 10.15190/d.2025.6 · Discoveries · 2025-05-10

## TL;DR

This paper reviews how stimulant abuse affects the cardiovascular system, highlighting risks like heart disease and suggesting ways to improve public health.

## Contribution

The paper provides a comprehensive overview of stimulant-induced cardiovascular effects and emphasizes the need for targeted interventions.

## Key findings

- Chronic stimulant use increases cardiovascular risk, leading to severe conditions like hypertension and myocardial infarction.
- Stimulants cause direct effects such as arrhythmias and atherosclerosis, which progress to more severe pathologies over time.
- The review highlights the importance of public education and personalized medical approaches to reduce stimulant-related cardiovascular mortality.

## Abstract

This comprehensive review explores the intricate relationship between stimulants abuse, particularly involving caffeine, amphetamines, methylphenidate and cocaine, offering a detailed and insightful overview of the multifaceted consequences of stimulant drug use on the cardiovascular system. Substance abuse is a medical and socioeconomic issue, which should be regarded properly with respect to its multifaceted implications. For instance, chronic usage exponentially increases the cardiovascular risk, leading to high morbidity and mortality rates. Arrhythmias, atherosclerosis, thrombosis and ischemia are just some of the direct effects of stimulants on vessels and heart, which lead in time to more severe pathological changes, such as hypertension, cardiomyopathies, valvulopathies, myocardial infarction, peripheral artery disease and other cerebrovascular diseases. The different approaches and diverse perspectives of this review, highlight the clinical significance of this complex field. Moreover, opportunities for further research and exploration are pointed out, thus  promoting public education, personalized medical approaches, and targeted interventions to mitigate the substantial morbidity and mortality linked to stimulant abuse. Hopefully, this effort will enhance public cardiovascular well-being.

## Linked entities

- **Chemicals:** caffeine (PubChem CID 2519), methylphenidate (PubChem CID 4158), cocaine (PubChem CID 2826)
- **Diseases:** cardiomyopathies (MONDO:0004994), myocardial infarction (MONDO:0005068)

## Full-text entities

- **Diseases:** Substance abuse (MESH:D019966), peripheral artery disease (MESH:D058729), thrombosis (MESH:D013927), atherosclerosis (MESH:D050197), cardiomyopathies (MESH:D009202), myocardial infarction (MESH:D009203), stimulant abuse (MESH:D007037), hypertension (MESH:D006973), cerebrovascular diseases (MESH:D002561), Arrhythmias (MESH:D001145), ischemia (MESH:D007511)
- **Chemicals:** cocaine (MESH:D003042), methylphenidate (MESH:D008774), caffeine (MESH:D002110), amphetamines (MESH:D000662)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12245559/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12245559/full.md

## References

173 references — full list in the complete paper: https://tomesphere.com/paper/PMC12245559/full.md

---
Source: https://tomesphere.com/paper/PMC12245559